4.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pluri Inc Borsa (PLUR) Ultime notizie
Using cell science to fight nuclear weapons: How is Pluri revolutionizing health and food tech? - The Jerusalem Post
Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Forecast: Ke... - WhaTech
Pluri Inc. partners with Hemafund for radiation emergency response By Investing.com - Investing.com Canada
Pluri Inc. and Hemafund partner for radiation emergency pre By Investing.com - Investing.com Canada
Pluri signs deal to help Ukraine's radiation emergency preparedness - The Pharma Letter
Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise - Marketscreener.com
Pluri Inc. and Hemafund partner for radiation emergency pre - Investing.com India
Pluri Inc. partners with Hemafund for radiation emergency response - Investing.com
Pluri announces exclusive collaboration agreement with Hemafund - TipRanks
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness - The Manila Times
Can Pluri's Radiation Therapy Save Lives in Ukraine's Nuclear Crisis? - StockTitan
Head-To-Head Survey: Pluri (NASDAQ:PLUR) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
EAF and Buhler announce collaboration - TipRanks
Can This New Technology Finally Make Lab-Grown Meat Affordable? Ever After Foods Says Yes - StockTitan
Pluri Announces Strategic Merger to Enhance Market Position - TipRanks
Pluri Proposes Extension of Convertible Bond Maturity to Key Investor - TipRanks
Pluri: Fiscal Q2 Earnings Snapshot - CT Insider
Pluri: Fiscal Q2 Earnings Snapshot -February 11, 2025 at 05:38 pm EST - Marketscreener.com
Pluri Inc. Faces Financial Challenges Amid Continued Innovation - TipRanks
Pluri Inc. SEC 10-Q Report - TradingView
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology - Business Wire
Pluri Ltd. Strengthens Financial Position Through Capital Raising - TipRanks
Romanian Fintech Company Pluridio is Expanding its Global Presence by Opening a Subsidiary in the UK - PR Newswire
Plurilock Security (CVE:PLUR) Trading Up 4% – Should You Buy? - Defense World
Pluri (NASDAQ:PLUR) Trading Down 4.4% – Time to Sell? - Defense World
Pluri secures additional $3.5 million investment - MSN
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million - The Manila Times
The Month In Cultivated Meat: January - substack.com
Pluri Inc. Announces Appointment of Alejandro Weinstein to Board of Directors -January 23, 2025 at 07:15 am EST - Marketscreener.com
Liberation labs raises $50.5m: The Week in AgriFoodTech - AgFunderNews
Pluri Strengthens Leadership Amid Strategic Board Appointment - TipRanks
Adipose-Derived Stem Cell Market to Reach $3013.9 Million by 2030. - openPR
Pluri Inc. granted extension to regain Nasdaq compliance - MSN
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market - Yahoo Finance
BeZero closes $32m round: The Week in AgriFoodTech - AgFunderNews
Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao Producer Kokomodovegconomist - vegconomist - the vegan business magazine
Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - The Manila Times
Pluri Secures $6.5M Premium Investment, Acquires Majority Stake in Cultivated Cacao Pioneer - StockTitan
Comparing Adverum Biotechnologies (NASDAQ:ADVM) & Pluri (NASDAQ:PLUR) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World
BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS… - MSN
Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development - Business Wire
Head to Head Review: Pluri (NASDAQ:PLUR) & Gilead Sciences (NASDAQ:GILD) - Defense World
Pluristem stock touches 52-week low at $4.11 amid market challenges - Investing.com India
Pluristem stock touches 52-week low at $4.11 amid market challenges By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):